Cylene Pharmaceuticals, TetraGene deal

Cylex granted TetraGene an option to acquire exclusive, worldwide rights to Cylene's associated anticancer quadruplex-targeting technologies, including Quarfloxin. Cylex will receive an undisclosed up...